A National Collaborative Multicenter Phase II Study for Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19
2020-07-04
عنوان الدراسة
A National Collaborative Multicenter Phase II Study for Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19
داعم الدراسة
GDRS (MOH)
دواء الدراسة
Convalescent Plasma
رقم بروتوكول الدراسة
20-COVID-19-01M
حالة الدراسة
Ongoing
موقع الدراسة
King Fahad Specialist Hospital (Dammam), International Medical Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah), King Abdulaziz Hospital NG (Al Ahsa), Prince Mohammad bin Abdulaziz Hospital NG (Medina), Qatif Central Hospital, Dammam Medical Complex, King Fahad Medical City (Riyadh), King Saud Medical City (Riyadh), King Abdullah Medical City (Makkah), Al-Noor Specialist Hospital (Makkah), King Abdullah Medical Complex (Jeddah), Ohud hospital (Medina), King Fahad Genaral Hospital (Medina), Aseer Central Hospital (Abha)
مرحلة الدراسة
2
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.